About Rebif® (interferon beta-1a)
Rebif is the only self-injected relapsing MS therapy proven to meet all 3 key treatment goals in relapsing MS
This was shown in a large placebo-controlled study of interferon therapy for relapsing MS.
|
Slowing disability progression
|
Reducing relapse rate
|
Reducing brain lesions on all studied MRI measures*†
|
|---|---|---|
| Yes | Yes | Yes |
†Refers to new lesion burden or area as defined in the AAN and MS Council guidelines.
*The exact correlation between MRI findings and the current or future clinical status of patients, including disability progression, is unknown.
How does Rebif work?
Rebif is an interferon therapy. Interferons belong to a family of proteins that naturally occur in the body. Rebif contains specifically interferon beta-1a. This type of interferon is identical to the body's natural human interferon beta. The exact way Rebif works is not known.
Although there is no cure for relapsing MS, Rebif has been proven to slow the progression of disability, which is the permanent worsening of your neurologic examination over time.
Learn more about the benefits of Rebif.
Before beginning treatment, you should discuss with your doctor the potential benefits and risks associated with Rebif. Let your doctor know if you have a history of depression, seizures, liver disease, thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions to medications.
Please see important safety information below and the Rebif Medication Guide and Prescribing Information in the top right corner of this website, and speak with your doctor for more information.
